Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-azabicyclo(2.2.1)heptan-3-one, O-(3-(3-methoxyphenyl)-2-propynyl)oxime Ethanedioate
2. Ci-1017
3. Pd 142505-0028
4. Pd 142505-0028, ((+-)-z)-isomer
5. Pd 142505-0028, ((1r)-z)-isomer
6. Pd 142505-0028, ((1s)-z)-isomer
7. Pd-142505-0028
1. 161774-09-0
2. Ci-1017
3. (e)-n-[3-(3-methoxyphenyl)prop-2-ynoxy]-1-azabicyclo[2.2.1]heptan-3-imine;oxalic Acid
4. 1-azabicyclo(2.2.1)heptan-3-one, O-(3-(3-methoxyphenyl)-2-propynyl)oxime Ethanedioate
5. Pd-142505-0028
| Molecular Weight | 360.4 g/mol |
|---|---|
| Molecular Formula | C18H20N2O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 360.13213636 g/mol |
| Monoisotopic Mass | 360.13213636 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 506 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Ci-1017 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ci-1017, including repackagers and relabelers. The FDA regulates Ci-1017 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ci-1017 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ci-1017 supplier is an individual or a company that provides Ci-1017 active pharmaceutical ingredient (API) or Ci-1017 finished formulations upon request. The Ci-1017 suppliers may include Ci-1017 API manufacturers, exporters, distributors and traders.
click here to find a list of Ci-1017 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ci-1017 DMF (Drug Master File) is a document detailing the whole manufacturing process of Ci-1017 active pharmaceutical ingredient (API) in detail. Different forms of Ci-1017 DMFs exist exist since differing nations have different regulations, such as Ci-1017 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ci-1017 DMF submitted to regulatory agencies in the US is known as a USDMF. Ci-1017 USDMF includes data on Ci-1017's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ci-1017 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ci-1017 suppliers with USDMF on PharmaCompass.
Ci-1017 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ci-1017 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ci-1017 GMP manufacturer or Ci-1017 GMP API supplier for your needs.
A Ci-1017 CoA (Certificate of Analysis) is a formal document that attests to Ci-1017's compliance with Ci-1017 specifications and serves as a tool for batch-level quality control.
Ci-1017 CoA mostly includes findings from lab analyses of a specific batch. For each Ci-1017 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ci-1017 may be tested according to a variety of international standards, such as European Pharmacopoeia (Ci-1017 EP), Ci-1017 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ci-1017 USP).
LOOKING FOR A SUPPLIER?
